메뉴 건너뛰기




Volumn 10, Issue 2, 2009, Pages 88-97

The prevention, recognition and treatment of post-ERCP pancreatitis

Author keywords

Cholangiopancreatography, endoscopic retrograde; Pancreatitis, acute necrotizing; Review; Stents; Therapeutics

Indexed keywords

ADRENALIN; ALLOPURINOL; BETA CAROTENE; CEFTAZIDIME; CORTICOSTEROID; DICLOFENAC; GABEXATE; GLYCERYL TRINITRATE; HEPARIN; HYDROCORTISONE; INTERLEUKIN 10; LIDOCAINE; METHYLPREDNISOLONE; NIFEDIPINE; OCTREOTIDE; PLACEBO; PREDNISOLONE; SOMATOSTATIN; ULINASTATIN;

EID: 66149124854     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (66)

References (122)
  • 1
    • 3042709608 scopus 로고    scopus 로고
    • Prevention of Post-ERCP Pancreatitis: A comprehensive review
    • Freeman ML, Guda NM. Prevention of Post-ERCP Pancreatitis: a comprehensive review. Gastrointest Endosc 2004; 59:845-64.
    • (2004) Gastrointest Endosc , vol.59 , pp. 845-864
    • Freeman, M.L.1    Guda, N.M.2
  • 4
    • 0031878848 scopus 로고    scopus 로고
    • Predictors of post-ERCP complications in patients with suspected choledocholithiasis
    • Mehta SN, Pavone E, Barkun JS, Bouchard S, Barkun AN. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998; 30:457-63.
    • (1998) Endoscopy , vol.30 , pp. 457-463
    • Mehta, S.N.1    Pavone, E.2    Barkun, J.S.3    Bouchard, S.4    Barkun, A.N.5
  • 5
    • 33749170457 scopus 로고    scopus 로고
    • Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in Acute Pancreatitis
    • Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in Acute Pancreatitis. Am J Gastroenterol 2006; 101:2379-2400.
    • (2006) Am J Gastroenterol , vol.101 , pp. 2379-2400
    • Banks, P.A.1    Freeman, M.L.2
  • 6
    • 0031968113 scopus 로고    scopus 로고
    • Endoscopic pancreatic sphincterotomy: Indications, outcome, and a safe stentless technique
    • Elton E, Howell DA, Parsons WG, Qaseem T, Hanson BL. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998; 47:240-249.
    • (1998) Gastrointest Endosc , vol.47 , pp. 240-249
    • Elton, E.1    Howell, D.A.2    Parsons, W.G.3    Qaseem, T.4    Hanson, B.L.5
  • 7
    • 0029738350 scopus 로고    scopus 로고
    • Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes
    • Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman GA. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 1996; 91:1553-61.
    • (1996) Am J Gastroenterol , vol.91 , pp. 1553-1561
    • Gottlieb, K.1    Sherman, S.2    Pezzi, J.3    Esber, E.4    Lehman, G.A.5
  • 9
    • 0033135802 scopus 로고    scopus 로고
    • Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis
    • Testoni PA, Bagnolo F, Caporuscio S, Lella F. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 1999; 94:1235-41.
    • (1999) Am J Gastroenterol , vol.94 , pp. 1235-1241
    • Testoni, P.A.1    Bagnolo, F.2    Caporuscio, S.3    Lella, F.4
  • 10
    • 14844316062 scopus 로고
    • Effect of xanthine oxidase inhibition with allopurinol on the incidence and severity of post-ERCP pancreatitis and hyperamylasemia in a prospective randomized, double-blind, placebo-controlled clinical trial of 168 patients
    • Clemens JA, Bulkley GB, Cameron JL, Milligan FL, Hutcheson DL, Horn SD. Effect of xanthine oxidase inhibition with allopurinol on the incidence and severity of post-ERCP pancreatitis and hyperamylasemia in a prospective randomized, double-blind, placebo-controlled clinical trial of 168 patients. Gastroenterology 1991; 100:A270.
    • (1991) Gastroenterology , vol.100
    • Clemens, J.A.1    Bulkley, G.B.2    Cameron, J.L.3    Milligan, F.L.4    Hutcheson, D.L.5    Horn, S.D.6
  • 11
    • 0034840051 scopus 로고    scopus 로고
    • A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis
    • Budzyńska A, Marek T, Nowak A, Kaczor R, Nowakowska-Dulawa E. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001; 33:766-72.
    • (2001) Endoscopy , vol.33 , pp. 766-772
    • Budzyńska, A.1    Marek, T.2    Nowak, A.3    Kaczor, R.4    Nowakowska-Dulawa, E.5
  • 12
    • 14844283150 scopus 로고    scopus 로고
    • High-dose allopurinol for prevention of post-ERCP pancreatitis: A prospective randomized double-blind controlled trial
    • Katsinelos P, Kountouras J, Chatzis J, Christodoulou K, Paroutoglou G, Mimidis K, et al. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc 2005; 61:407-15.
    • (2005) Gastrointest Endosc , vol.61 , pp. 407-415
    • Katsinelos, P.1    Kountouras, J.2    Chatzis, J.3    Christodoulou, K.4    Paroutoglou, G.5    Mimidis, K.6
  • 14
    • 33745432218 scopus 로고    scopus 로고
    • N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis
    • Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol 2006; 12:3751-5.
    • (2006) World J Gastroenterol , vol.12 , pp. 3751-3755
    • Milewski, J.1    Rydzewska, G.2    Degowska, M.3    Kierzkiewicz, M.4    Rydzewski, A.5
  • 18
    • 33646829315 scopus 로고    scopus 로고
    • Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study
    • Kwanngern K, Tiyapattanaputi P, Wanitpukdeedecha M, Navicharern P. Can a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study. J Med Assoc Thai 2005; 88:Suppl4:S42-5.
    • (2005) J Med Assoc Thai , vol.88 , Issue.SUPPL.4
    • Kwanngern, K.1    Tiyapattanaputi, P.2    Wanitpukdeedecha, M.3    Navicharern, P.4
  • 19
    • 0033106487 scopus 로고    scopus 로고
    • Use of corticosteriods in the prevention of post-ERCP pancreatitis: Results of a controlled prospective study
    • De Palma GD, Catanzano C. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999; 94:982-5.
    • (1999) Am J Gastroenterol , vol.94 , pp. 982-985
    • De Palma, G.D.1    Catanzano, C.2
  • 20
    • 0032426654 scopus 로고    scopus 로고
    • Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: A randomized, multicenter, placebo-controlled clinical trial
    • Dumot JA, Conwell DL, O'Connor JB, Ferguson DR, Vargo JJ, Barnes DS, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 1998; 93:61-5.
    • (1998) Am J Gastroenterol , vol.93 , pp. 61-65
    • Dumot, J.A.1    Conwell, D.L.2    O'Connor, J.B.3    Ferguson, D.R.4    Vargo, J.J.5    Barnes, D.S.6
  • 21
    • 0347442019 scopus 로고    scopus 로고
    • Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: A randomized, prospective, multicenter study
    • Sherman S, Blaut U, Watkins JL, Barnett J, Freeman M, Geenen J, et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003; 58:23-9.
    • (2003) Gastrointest Endosc , vol.58 , pp. 23-29
    • Sherman, S.1    Blaut, U.2    Watkins, J.L.3    Barnett, J.4    Freeman, M.5    Geenen, J.6
  • 22
    • 0038386052 scopus 로고    scopus 로고
    • Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography
    • Murray B, Carter R, Imrie C, Evans S, O'Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003; 124:1786-91.
    • (2003) Gastroenterology , vol.124 , pp. 1786-1791
    • Murray, B.1    Carter, R.2    Imrie, C.3    Evans, S.4    O'Suilleabhain, C.5
  • 25
  • 27
    • 33747196615 scopus 로고    scopus 로고
    • Efficacy of Recombinant Human Interleukin-10 in Prevention of Acute Pancreatitis After ERCP in Subjects with Increased Risk: Randomized Prospective Multicenter Study
    • Sherman S, Chen CL, Costamagna G, Binmoeller KF, Puespoek A, Aithal GP, et al. Efficacy of Recombinant Human Interleukin-10 in Prevention of Acute Pancreatitis After ERCP in Subjects with Increased Risk: Randomized Prospective Multicenter Study. Gastrointest Endosc 2005; 61:AB99.
    • (2005) Gastrointest Endosc , vol.61
    • Sherman, S.1    Chen, C.L.2    Costamagna, G.3    Binmoeller, K.F.4    Puespoek, A.5    Aithal, G.P.6
  • 28
    • 0035676599 scopus 로고    scopus 로고
    • Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis
    • Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001; 88:1178-82.
    • (2001) Br J Surg , vol.88 , pp. 1178-1182
    • Sudhindran, S.1    Bromwich, E.2    Edwards, P.R.3
  • 29
    • 0037280967 scopus 로고    scopus 로고
    • Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial
    • Moretó M, Zaballa M, Casado I, Merino O, Rueda M, Ramírez K, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc 2003; 57:1-7.
    • (2003) Gastrointest Endosc , vol.57 , pp. 1-7
    • Moretó, M.1    Zaballa, M.2    Casado, I.3    Merino, O.4    Rueda, M.5    Ramírez, K.6
  • 30
    • 33747164545 scopus 로고    scopus 로고
    • A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: Effects on technical success and post-ERCP pancreatitis
    • Kaffes AJ, Bourke MJ, Ding S, Alrubaie A, Kwan V, Williams SJ. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006; 64:351-7.
    • (2006) Gastrointest Endosc , vol.64 , pp. 351-357
    • Kaffes, A.J.1    Bourke, M.J.2    Ding, S.3    Alrubaie, A.4    Kwan, V.5    Williams, S.J.6
  • 31
    • 0036675259 scopus 로고    scopus 로고
    • Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study
    • Prat F, Amaris J, Ducot B, Bocquentin M, Fritsch J, Choury AD, et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002; 56:202-8.
    • (2002) Gastrointest Endosc , vol.56 , pp. 202-208
    • Prat, F.1    Amaris, J.2    Ducot, B.3    Bocquentin, M.4    Fritsch, J.5    Choury, A.D.6
  • 32
    • 0027318617 scopus 로고
    • Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography
    • Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion 1993; 54:179-84.
    • (1993) Digestion , vol.54 , pp. 179-184
    • Sand, J.1    Nordback, I.2
  • 33
    • 1042301318 scopus 로고    scopus 로고
    • The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis
    • Schwartz JJ, Lew RJ, Ahmad NA, Shah JN, Ginsberg GG, Kochman ML, et al. The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc 2004; 59:179-84.
    • (2004) Gastrointest Endosc , vol.59 , pp. 179-184
    • Schwartz, J.J.1    Lew, R.J.2    Ahmad, N.A.3    Shah, J.N.4    Ginsberg, G.G.5    Kochman, M.L.6
  • 35
    • 0035722422 scopus 로고    scopus 로고
    • Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty
    • Ohashi A, Tamada K, Tomiyama T, Wada S, Higashizawa T, Gotoh Y, et al. Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty. J Gastroenterol Hepatol 2001; 16:568-71.
    • (2001) J Gastroenterol Hepatol , vol.16 , pp. 568-571
    • Ohashi, A.1    Tamada, K.2    Tomiyama, T.3    Wada, S.4    Higashizawa, T.5    Gotoh, Y.6
  • 36
    • 0013163856 scopus 로고    scopus 로고
    • Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP?
    • Rabenstein T, Roggenbuck S, Framke B, Martus P, Fischer B, Nusko G, et al. Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002; 55:476-83.
    • (2002) Gastrointest Endosc , vol.55 , pp. 476-483
    • Rabenstein, T.1    Roggenbuck, S.2    Framke, B.3    Martus, P.4    Fischer, B.5    Nusko, G.6
  • 39
    • 0027367644 scopus 로고    scopus 로고
    • Pederzoli P, Cavallini G, Falconi M, Bassi C. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study. Int J Pancreatol 1993; 14:117-24.
    • Pederzoli P, Cavallini G, Falconi M, Bassi C. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study. Int J Pancreatol 1993; 14:117-24.
  • 41
    • 0005925046 scopus 로고    scopus 로고
    • Multicenter double-blind study of Gabexate-mesilate (Foy), given intravenously in low dose in acute pancreatitis
    • Goebell H. Multicenter double-blind study of Gabexate-mesilate (Foy), given intravenously in low dose in acute pancreatitis. Digestion 1998; 40:83.
    • (1998) Digestion , vol.40 , pp. 83
    • Goebell, H.1
  • 43
    • 0023493713 scopus 로고
    • Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis
    • Yang CY, Chang-Chien CS, Liaw YF. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis. Pancreas 1987; 2:698-700.
    • (1987) Pancreas , vol.2 , pp. 698-700
    • Yang, C.Y.1    Chang-Chien, C.S.2    Liaw, Y.F.3
  • 44
    • 0029788508 scopus 로고    scopus 로고
    • Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group
    • Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996; 335:919-23.
    • (1996) N Engl J Med , vol.335 , pp. 919-923
    • Cavallini, G.1    Tittobello, A.2    Frulloni, L.3    Masci, E.4    Mariana, A.5    Di Francesco, V.6
  • 45
    • 10144219745 scopus 로고
    • Effect of a new enzyme inhibitor (Gabexate Mesilate-FOY) on hyperenzymemia induced by ERCP. A double blind study
    • Benini L, Angelini G, Lavarini E, Brocco G, Cavallini G, Merigo F. Effect of a new enzyme inhibitor (Gabexate Mesilate-FOY) on hyperenzymemia induced by ERCP. A double blind study. Digestion 1985; 32:A165.
    • (1985) Digestion , vol.32
    • Benini, L.1    Angelini, G.2    Lavarini, E.3    Brocco, G.4    Cavallini, G.5    Merigo, F.6
  • 46
    • 3242696584 scopus 로고
    • Prophylactic effects of preoperative administration of Gabexate Mesilate (FOY) on post-ERCP pancreatitis
    • Shimizu Y, Takahashi H, Deura M, Aizawa Y, Zenitani M, Akiba M. Prophylactic effects of preoperative administration of Gabexate Mesilate (FOY) on post-ERCP pancreatitis. Gendai Iryo 1979; 11:540-4.
    • (1979) Gendai Iryo , vol.11 , pp. 540-544
    • Shimizu, Y.1    Takahashi, H.2    Deura, M.3    Aizawa, Y.4    Zenitani, M.5    Akiba, M.6
  • 47
    • 3242687571 scopus 로고
    • Effect of FOY on hyperamylasemia after endoscopic retrograde cholangiopancreatography
    • Hajiro K, Tsujimura D, Inoue R, Yamamoto H, Yamamoto T. Effect of FOY on hyperamylasemia after endoscopic retrograde cholangiopancreatography. Gendai Iryo 1978; 10:1375-9.
    • (1978) Gendai Iryo , vol.10 , pp. 1375-1379
    • Hajiro, K.1    Tsujimura, D.2    Inoue, R.3    Yamamoto, H.4    Yamamoto, T.5
  • 48
    • 0344154185 scopus 로고
    • Study on prevention of complication associated with endoscopic retrograde cholangiopancreatography (ERCP): A controlled trial of a new protease inhibitor, FOY, in hyperamylasemia following endoscopic retrograde cholangiopancreatography
    • Kuno N, Kasugai T, Oguri T, Matsuura A. Study on prevention of complication associated with endoscopic retrograde cholangiopancreatography (ERCP): a controlled trial of a new protease inhibitor, FOY, in hyperamylasemia following endoscopic retrograde cholangiopancreatography. Gendai Iryo 1978; 10:571-5.
    • (1978) Gendai Iryo , vol.10 , pp. 571-575
    • Kuno, N.1    Kasugai, T.2    Oguri, T.3    Matsuura, A.4
  • 49
    • 33947379484 scopus 로고
    • Wirkung des synthetischen proteinase-inhibitors foy auf die hyperamylasamia nach ERP
    • Grozinger KH, Schrey A, Wabnitz RW, Editors, Munchen, Germany
    • Salamon V, Kuntz HD, May B. Wirkung des synthetischen proteinase-inhibitors foy auf die hyperamylasamia nach ERP. In: Grozinger KH, Schrey A, Wabnitz RW, Editors, Proteinasen-Inhibition, FOY Workshop, 1981, Dusseldorf, Germany, Wolf G & Sohn, Munchen, Germany (1982):132-5.
    • (1982) Proteinasen-Inhibition, FOY Workshop, 1981, Dusseldorf, Germany, Wolf G & Sohn , pp. 132-135
    • Salamon, V.1    Kuntz, H.D.2    May, B.3
  • 51
    • 0037271126 scopus 로고    scopus 로고
    • Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: The evidence-based medicine derived from a meta-analysis study. JOP.J
    • Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, De Maio G. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP.J Pancreas (Online) 2003; 4:41-8.
    • (2003) Pancreas (Online) , vol.4 , pp. 41-48
    • Andriulli, A.1    Caruso, N.2    Quitadamo, M.3    Forlano, R.4    Leandro, G.5    Spirito, F.6    De Maio, G.7
  • 52
    • 33947420914 scopus 로고    scopus 로고
    • Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: An updated meta-analysis
    • Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007; 65:624-32.
    • (2007) Gastrointest Endosc , vol.65 , pp. 624-632
    • Andriulli, A.1    Leandro, G.2    Federici, T.3    Ippolito, A.4    Forlano, R.5    Iacobellis, A.6    Annese, V.7
  • 53
    • 18344404181 scopus 로고    scopus 로고
    • Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial
    • Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002; 56:488-95.
    • (2002) Gastrointest Endosc , vol.56 , pp. 488-495
    • Andriulli, A.1    Clemente, R.2    Solmi, L.3    Terruzzi, V.4    Suriani, R.5    Sigillito, A.6
  • 54
    • 26144477321 scopus 로고    scopus 로고
    • Gruppo Gabesato Endoscopia Digestiva (GRIGED). Comparison of two dosing regimens of gabexate mesilate (FOY® in the prevention of post-ercp pancreatitis: Results of a multicentre controlled trial
    • Mariani A, Frulloni L, Masci E, Curioni S, Tittobello A, Cavallini G, Gruppo Gabesato Endoscopia Digestiva (GRIGED). Comparison of two dosing regimens of gabexate mesilate (FOY® in the prevention of post-ercp pancreatitis: Results of a multicentre controlled trial. Dig Liver Dis 2001; 33(Suppl 1):A36.
    • (2001) Dig Liver Dis , vol.33 , Issue.SUPPL. 1
    • Mariani, A.1    Frulloni, L.2    Masci, E.3    Curioni, S.4    Tittobello, A.5    Cavallini, G.6
  • 55
    • 3543028668 scopus 로고    scopus 로고
    • Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate
    • Andriulli A, Solmi L, Loperfido S, Leo P, Festa V, Belmonte A, et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2004; 2:713-8.
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 713-718
    • Andriulli, A.1    Solmi, L.2    Loperfido, S.3    Leo, P.4    Festa, V.5    Belmonte, A.6
  • 56
    • 30744445707 scopus 로고    scopus 로고
    • Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis
    • Xiong GS, Wu SM, Zhang XW, Ge ZZ. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res 2006; 39:85-90.
    • (2006) Braz J Med Biol Res , vol.39 , pp. 85-90
    • Xiong, G.S.1    Wu, S.M.2    Zhang, X.W.3    Ge, Z.Z.4
  • 58
    • 33847649314 scopus 로고    scopus 로고
    • Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomized placebo controlled multicenter study
    • Benvenuti S, Zancanella L, Piazzi L, Comberlato M, Chilovi F, Germana B, et al. Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomized placebo controlled multicenter study. Dig Liver Dis 2006; 38(Suppl 1):S15.
    • (2006) Dig Liver Dis , vol.38 , Issue.SUPPL. 1
    • Benvenuti, S.1    Zancanella, L.2    Piazzi, L.3    Comberlato, M.4    Chilovi, F.5    Germana, B.6
  • 59
    • 34249105198 scopus 로고    scopus 로고
    • Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: A randomized, controlled, multicenter study
    • Manes G, Ardizzone S, Lombardi G, Uomo G, Pieramico O, Porro GB. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc 2007; 65:982-7.
    • (2007) Gastrointest Endosc , vol.65 , pp. 982-987
    • Manes, G.1    Ardizzone, S.2    Lombardi, G.3    Uomo, G.4    Pieramico, O.5    Porro, G.B.6
  • 60
    • 33744754140 scopus 로고    scopus 로고
    • Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study
    • Fujishiro H, Adachi K, Imaoka T, Hashimoto T, Kohge N, Moriyama N, et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol 2006; 21:1065-9.
    • (2006) J Gastroenterol Hepatol , vol.21 , pp. 1065-1069
    • Fujishiro, H.1    Adachi, K.2    Imaoka, T.3    Hashimoto, T.4    Kohge, N.5    Moriyama, N.6
  • 61
    • 34147150750 scopus 로고    scopus 로고
    • Risk for Post-ERCP Pancreatitis After Needle Knife Precut Sphincterotomy Following Repeated Cannulation Attempts
    • Lee JK, Park JK, Yoon WJ, Lee SH, Lee KH, Ryu JK, et al. Risk for Post-ERCP Pancreatitis After Needle Knife Precut Sphincterotomy Following Repeated Cannulation Attempts. J Clin Gastroenterol 2007; 41:427-31.
    • (2007) J Clin Gastroenterol , vol.41 , pp. 427-431
    • Lee, J.K.1    Park, J.K.2    Yoon, W.J.3    Lee, S.H.4    Lee, K.H.5    Ryu, J.K.6
  • 62
    • 33947165306 scopus 로고    scopus 로고
    • Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective, randomized trial
    • Ueki T, Otani K, Kawamoto K, Shimizu A, Fujimura N, Sakaguchi S, Matsui T. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol 2007; 42:161-7.
    • (2007) J Gastroenterol , vol.42 , pp. 161-167
    • Ueki, T.1    Otani, K.2    Kawamoto, K.3    Shimizu, A.4    Fujimura, N.5    Sakaguchi, S.6    Matsui, T.7
  • 63
    • 33748504990 scopus 로고    scopus 로고
    • Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: A 6-year survey and cost-effectiveness analysis
    • Testoni PA, Mariani A, Masci E, Curioni S. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis. Dig Liver Dis 2006; 38:588-95.
    • (2006) Dig Liver Dis , vol.38 , pp. 588-595
    • Testoni, P.A.1    Mariani, A.2    Masci, E.3    Curioni, S.4
  • 64
    • 34347398134 scopus 로고    scopus 로고
    • Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: Meta-analysis of randomized placebo-controlled trials
    • Rudin D, Kiss A, Wetz RV, Sottile VM. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol 2007; 22:977-83.
    • (2007) J Gastroenterol Hepatol , vol.22 , pp. 977-983
    • Rudin, D.1    Kiss, A.2    Wetz, R.V.3    Sottile, V.M.4
  • 65
    • 0036290633 scopus 로고    scopus 로고
    • Chen SY, Wang JY. Ulinastatin in the treatment of acute pancreatitis: a multicenter clinical trial. Chin J Dig Dis 2002; 3:70-5.
    • Chen SY, Wang JY. Ulinastatin in the treatment of acute pancreatitis: a multicenter clinical trial. Chin J Dig Dis 2002; 3:70-5.
  • 66
    • 20144387532 scopus 로고    scopus 로고
    • Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial
    • Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005; 3:376-83.
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 376-383
    • Tsujino, T.1    Komatsu, Y.2    Isayama, H.3    Hirano, K.4    Sasahira, N.5    Yamamoto, N.6
  • 67
    • 0026092644 scopus 로고
    • Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis
    • Guelrud M, Mendoza S, Viera L, Gelrud D. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 1991; 37:44-7.
    • (1991) Gastrointest Endosc , vol.37 , pp. 44-47
    • Guelrud, M.1    Mendoza, S.2    Viera, L.3    Gelrud, D.4
  • 69
    • 0031978291 scopus 로고    scopus 로고
    • Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: Results of a randomized study
    • Bordas JM, Toledo-Pimentel V, Llach J, Elena M, Mondelo F, Gines A, Teres J. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc 1998; 47:230-4.
    • (1998) Gastrointest Endosc , vol.47 , pp. 230-234
    • Bordas, J.M.1    Toledo-Pimentel, V.2    Llach, J.3    Elena, M.4    Mondelo, F.5    Gines, A.6    Teres, J.7
  • 70
    • 0032962285 scopus 로고    scopus 로고
    • Prophylactic effect of somatostatin on post-ERCP pancreatitis: A randomized controlled trial
    • Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999; 49:593-8.
    • (1999) Gastrointest Endosc , vol.49 , pp. 593-598
    • Poon, R.T.1    Yeung, C.2    Lo, C.M.3    Yuen, W.K.4    Liu, C.L.5    Fan, S.T.6
  • 71
    • 0344665557 scopus 로고    scopus 로고
    • Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: A randomised controlled trial
    • Poon RT, Yeung C, Liu CL, Lam CM, Yuen WK, Lo CM, et al. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut 2003; 52:1768-73.
    • (2003) Gut , vol.52 , pp. 1768-1773
    • Poon, R.T.1    Yeung, C.2    Liu, C.L.3    Lam, C.M.4    Yuen, W.K.5    Lo, C.M.6
  • 73
    • 0021366588 scopus 로고
    • Effect of somatostatin on amylase level and pancreatitis rate following ERCP
    • Börsch G, Bergbauer M, Nebel W, Sabin G. Effect of somatostatin on amylase level and pancreatitis rate following ERCP. Med Welt 1984; 35:109-12.
    • (1984) Med Welt , vol.35 , pp. 109-112
    • Börsch, G.1    Bergbauer, M.2    Nebel, W.3    Sabin, G.4
  • 74
    • 0023804982 scopus 로고
    • Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy
    • Bordas JM, Toledo V, Mondelo F, Rodés J. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. Hormone Res 1988; 29:106-8.
    • (1988) Hormone Res , vol.29 , pp. 106-108
    • Bordas, J.M.1    Toledo, V.2    Mondelo, F.3    Rodés, J.4
  • 75
    • 0023952417 scopus 로고
    • Endoscopic papillo-sphincterotomy: Prevention of pancreatic reaction by somatostatin
    • Testoni PA, Masci E, Bagnolo F, Tittobello A. Endoscopic papillo-sphincterotomy: prevention of pancreatic reaction by somatostatin. Ital J Gastroenterol 1988; 20:70-3.
    • (1988) Ital J Gastroenterol , vol.20 , pp. 70-73
    • Testoni, P.A.1    Masci, E.2    Bagnolo, F.3    Tittobello, A.4
  • 76
    • 0023835532 scopus 로고
    • The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study
    • Saari A, Kivilaakso E, Schroder T. The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study. Surg Res Comm 1988; 2:271-8.
    • (1988) Surg Res Comm , vol.2 , pp. 271-278
    • Saari, A.1    Kivilaakso, E.2    Schroder, T.3
  • 79
    • 33646260686 scopus 로고    scopus 로고
    • Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: A controlled, non-randomized study
    • Vila JJ, Jiménez FJ, Prieto C, Borobio E, Juanmartiñena JF, Borda F. Utility of bolus somatostatin administration in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a controlled, non-randomized study. Gastroenterol Hepatol 2006; 29:231-6.
    • (2006) Gastroenterol Hepatol , vol.29 , pp. 231-236
    • Vila, J.J.1    Jiménez, F.J.2    Prieto, C.3    Borobio, E.4    Juanmartiñena, J.F.5    Borda, F.6
  • 80
    • 19044397920 scopus 로고    scopus 로고
    • Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial
    • Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis N, Papadimitriou N, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002; 55:470-5.
    • (2002) Gastrointest Endosc , vol.55 , pp. 470-475
    • Manolakopoulos, S.1    Avgerinos, A.2    Vlachogiannakos, J.3    Armonis, A.4    Viazis, N.5    Papadimitriou, N.6
  • 81
    • 0025969432 scopus 로고
    • The effect of long acting somatostatin analogue on enzyme changes after endoscopic pancreatography
    • Tulassay Z, Papp J. The effect of long acting somatostatin analogue on enzyme changes after endoscopic pancreatography, Gastrointest Endosc 1991; 37:48-50.
    • (1991) Gastrointest Endosc , vol.37 , pp. 48-50
    • Tulassay, Z.1    Papp, J.2
  • 82
    • 0026458151 scopus 로고
    • A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis
    • Sternlieb JM, Aronchick CA, Retig JN, Dabezies M, Saunders F, Goosenberg E, et al. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 1992; 87:1561-6.
    • (1992) Am J Gastroenterol , vol.87 , pp. 1561-1566
    • Sternlieb, J.M.1    Aronchick, C.A.2    Retig, J.N.3    Dabezies, M.4    Saunders, F.5    Goosenberg, E.6
  • 83
    • 0026612320 scopus 로고
    • Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
    • Binmoeller KF, Harris AG, Dumas R, Grimaldi C. Delmont JP. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 1992; 33:1129-33.
    • (1992) Gut , vol.33 , pp. 1129-1133
    • Binmoeller, K.F.1    Harris, A.G.2    Dumas, R.3    Grimaldi, C.4    Delmont, J.P.5
  • 84
    • 0027053444 scopus 로고
    • Influenza dell'octreotide sulla reazione pancreatica indotta da colangiopancreatografia retrograda.
    • Russo A, Virgilio C, Aprile G, Magnano A, Cosentino S. Influenza dell'octreotide sulla reazione pancreatica indotta da colangiopancreatografia retrograda. Giorn Ital End Dig 1992; 15:139-145.
    • (1992) Giorn Ital End Dig , vol.15 , pp. 139-145
    • Russo, A.1    Virgilio, C.2    Aprile, G.3    Magnano, A.4    Cosentino, S.5
  • 85
    • 0028606856 scopus 로고
    • Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy
    • Testoni PA, Lella F, Bagnolo F, Buizza M, Colombo E. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy. Ital J Gastroenterol 1994; 26:431-6.
    • (1994) Ital J Gastroenterol , vol.26 , pp. 431-436
    • Testoni, P.A.1    Lella, F.2    Bagnolo, F.3    Buizza, M.4    Colombo, E.5
  • 86
    • 0028605566 scopus 로고
    • The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy
    • Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, Zanasi G. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 1994; 26:715-8.
    • (1994) Endoscopy , vol.26 , pp. 715-718
    • Arcidiacono, R.1    Gambitta, P.2    Rossi, A.3    Grosso, C.4    Bini, M.5    Zanasi, G.6
  • 88
    • 0029888404 scopus 로고    scopus 로고
    • Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla
    • Testoni PA, Lella F, Bagnolo F, Caporuscio S, Cattani L, Colombo E, Buizza M. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla. Pancreas 1996;13:61-5.
    • (1996) Pancreas , vol.13 , pp. 61-65
    • Testoni, P.A.1    Lella, F.2    Bagnolo, F.3    Caporuscio, S.4    Cattani, L.5    Colombo, E.6    Buizza, M.7
  • 89
    • 0031768069 scopus 로고    scopus 로고
    • Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography
    • Tulassay Z, Döbrönte Z, Prónai L, Zágoni T, Juhász L. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment Pharmacol Ther 1998;12:1109-12.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 1109-1112
    • Tulassay, Z.1    Döbrönte, Z.2    Prónai, L.3    Zágoni, T.4    Juhász, L.5
  • 90
    • 0031914556 scopus 로고    scopus 로고
    • The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP
    • Arvanitidis D, Hatzipanayiotis J, Koutsounopoulos G, Frangou E. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP. Hepatogastroenterology 1998; 45:248-52.
    • (1998) Hepatogastroenterology , vol.45 , pp. 248-252
    • Arvanitidis, D.1    Hatzipanayiotis, J.2    Koutsounopoulos, G.3    Frangou, E.4
  • 91
    • 0034954886 scopus 로고    scopus 로고
    • Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: Results of a multicenter, randomized, controlled trial
    • Testoni PA, Bagnolo F, Andriulli A, Bernasconi G, Crotta S, Lella F, et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 2001;15:965-72.
    • (2001) Aliment Pharmacol Ther , vol.15 , pp. 965-972
    • Testoni, P.A.1    Bagnolo, F.2    Andriulli, A.3    Bernasconi, G.4    Crotta, S.5    Lella, F.6
  • 93
    • 34047114338 scopus 로고    scopus 로고
    • The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis
    • Kisli E, Baser M, Aydin M, Guler O. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis. Hepatogastroenterology 2007; 54:250-3.
    • (2007) Hepatogastroenterology , vol.54 , pp. 250-253
    • Kisli, E.1    Baser, M.2    Aydin, M.3    Guler, O.4
  • 94
    • 4744358079 scopus 로고    scopus 로고
    • The use of somatostatin or octreotide to prevent post-ERCP pancreatitis: A meta-analysis of randomized, controlled trials
    • Leung E. The use of somatostatin or octreotide to prevent post-ERCP pancreatitis: a meta-analysis of randomized, controlled trials. Gastrointest Endosc 2004; 59:AB107.
    • (2004) Gastrointest Endosc , vol.59
    • Leung, E.1
  • 96
    • 33846040777 scopus 로고    scopus 로고
    • Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial
    • Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 2006; 102:46-51.
    • (2006) Am J Gastroenterol , vol.102 , pp. 46-51
    • Li, Z.S.1    Pan, X.2    Zhang, W.J.3    Gong, B.4    Zhi, F.C.5    Guo, X.G.6
  • 97
    • 0017568492 scopus 로고
    • Effect of calcitonin on the serum amylase levels after endoscopic retrograde cholangiopancreatography
    • Odes HS, Novis BN, Barbezat GO, Bank S. Effect of calcitonin on the serum amylase levels after endoscopic retrograde cholangiopancreatography. Digestion 1977; 16:180-4.
    • (1977) Digestion , vol.16 , pp. 180-184
    • Odes, H.S.1    Novis, B.N.2    Barbezat, G.O.3    Bank, S.4
  • 98
    • 0016769889 scopus 로고
    • The role of glucagon in endoscopic cholangiopancreatography
    • Silvis SE, Vennes JA. The role of glucagon in endoscopic cholangiopancreatography. Gastrointest Endosc 1975; 21:162-3.
    • (1975) Gastrointest Endosc , vol.21 , pp. 162-163
    • Silvis, S.E.1    Vennes, J.A.2
  • 100
    • 0027258091 scopus 로고
    • Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients
    • Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993; 39:652-7.
    • (1993) Gastrointest Endosc , vol.39 , pp. 652-657
    • Smithline, A.1    Silverman, W.2    Rogers, D.3    Nisi, R.4    Wiersema, M.5    Jamidar, P.6
  • 101
    • 33748958175 scopus 로고    scopus 로고
    • Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study
    • Sherman S, Earle DT, Bucksot L, Baute P, Gottlieb K, Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? A final analysis of a randomized prospective study. Gastrointest Endosc 1996; 43:A489.
    • (1996) Gastrointest Endosc , vol.43
    • Sherman, S.1    Earle, D.T.2    Bucksot, L.3    Baute, P.4    Gottlieb, K.5    Lehman, G.6
  • 102
    • 0031729824 scopus 로고    scopus 로고
    • Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction
    • Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115:1518-24.
    • (1998) Gastroenterology , vol.115 , pp. 1518-1524
    • Tarnasky, P.R.1    Palesch, Y.Y.2    Cunningham, J.T.3    Mauldin, P.D.4    Cotton, P.B.5    Hawes, R.H.6
  • 103
    • 0002907128 scopus 로고    scopus 로고
    • Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized trial
    • Patel R, Tarnasky P, Hennessy WS, Hawes R, Payne KM, Nelles SE, et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy? Preliminary results of a prospective randomized trial. Gastrointest Endosc 1999; 49:AB80.
    • (1999) Gastrointest Endosc , vol.49
    • Patel, R.1    Tarnasky, P.2    Hennessy, W.S.3    Hawes, R.4    Payne, K.M.5    Nelles, S.E.6
  • 105
    • 0035431036 scopus 로고    scopus 로고
    • Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones
    • Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001; 54:209-13.
    • (2001) Gastrointest Endosc , vol.54 , pp. 209-213
    • Aizawa, T.1    Ueno, N.2
  • 106
    • 0036207119 scopus 로고    scopus 로고
    • Sphincter of Oddi dysfunction: Pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone
    • Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002; 34:280-5.
    • (2002) Endoscopy , vol.34 , pp. 280-285
    • Fogel, E.L.1    Eversman, D.2    Jamidar, P.3    Sherman, S.4    Lehman, G.A.5
  • 108
    • 0037344269 scopus 로고    scopus 로고
    • Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study
    • Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003; 57:291-4.
    • (2003) Gastrointest Endosc , vol.57 , pp. 291-294
    • Fazel, A.1    Quadri, A.2    Catalano, M.F.3    Meyerson, S.M.4    Geenen, J.E.5
  • 109
    • 0347003760 scopus 로고    scopus 로고
    • Pancreatic stent insertion: Consequences of failure and results of a modified technique to maximize success
    • Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004; 59:8-14.
    • (2004) Gastrointest Endosc , vol.59 , pp. 8-14
    • Freeman, M.L.1    Overby, C.2    Qi, D.3
  • 111
    • 23944465948 scopus 로고    scopus 로고
    • Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla
    • Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005; 62:367-70.
    • (2005) Gastrointest Endosc , vol.62 , pp. 367-370
    • Harewood, G.C.1    Pochron, N.L.2    Gostout, C.J.3
  • 112
    • 0043218906 scopus 로고    scopus 로고
    • Prophylactic pancreatic stenting for prevention of of Post-ERCP acute pancreatitis: A meta-analysis of controlled trials
    • Singh P, Sivak MV, Agarwal D, Wong R, Isenberg G, Das A, et al. Prophylactic pancreatic stenting for prevention of of Post-ERCP acute pancreatitis: a meta-analysis of controlled trials. Gastrointest Endosc 2003; 57:AB89.
    • (2003) Gastrointest Endosc , vol.57
    • Singh, P.1    Sivak, M.V.2    Agarwal, D.3    Wong, R.4    Isenberg, G.5    Das, A.6
  • 113
    • 34548358718 scopus 로고    scopus 로고
    • Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks
    • Andriulli A, Forlano R, Napolitano G, Conoscitore P, Caruso N, Pilotto A, et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 2007; 75:156-63.
    • (2007) Digestion , vol.75 , pp. 156-163
    • Andriulli, A.1    Forlano, R.2    Napolitano, G.3    Conoscitore, P.4    Caruso, N.5    Pilotto, A.6
  • 115
    • 34248661002 scopus 로고    scopus 로고
    • Pancreatic-stent placement for prevention of post-ERCP pancreatitis: A cost-effectiveness analysis
    • Das A, Singh P, Sivak MV Jr, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007; 65:960-8.
    • (2007) Gastrointest Endosc , vol.65 , pp. 960-968
    • Das, A.1    Singh, P.2    Sivak Jr, M.V.3    Chak, A.4
  • 116
    • 35549000027 scopus 로고    scopus 로고
    • Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
    • Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007; 5:1354-65.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 1354-1365
    • Freeman, M.L.1
  • 118
    • 34848901654 scopus 로고    scopus 로고
    • Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation
    • Artifon EL, Sakai P, Cunha JE, Halwan B, Ishioka S, Kumar A. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol 2007; 102:2147-53.
    • (2007) Am J Gastroenterol , vol.102 , pp. 2147-2153
    • Artifon, E.L.1    Sakai, P.2    Cunha, J.E.3    Halwan, B.4    Ishioka, S.5    Kumar, A.6
  • 122
    • 11144297110 scopus 로고    scopus 로고
    • Initial management of acute pancreatitis: Critical issues during the first 72 hours
    • Tenner S. Initial management of acute pancreatitis: critical issues during the first 72 hours. Am J Gastroenterol 2004; 99:2489-94.
    • (2004) Am J Gastroenterol , vol.99 , pp. 2489-2494
    • Tenner, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.